New clip device aims to control leaky heart valve in japanese patients
NCT ID NCT07509658
First seen Apr 19, 2026 · Last updated May 06, 2026 · Updated 3 times
Summary
This study looks at how well the TriClip system works and how safe it is for people in Japan with a leaky heart valve (tricuspid regurgitation). The device is already approved for use, and this study will follow 250 patients to confirm it controls the leak and has few complications. Participants get the standard treatment with the TriClip device, and doctors check their progress after 30 days.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRICUSPID REGURGITATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
National Cerebral & Cardiovascular Center Hospital
RECRUITINGSuita, Osaka, 564-8565, Japan
Contact
Conditions
Explore the condition pages connected to this study.